Putnam Investments’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,654,439
| Closed | -$5.31M | – | 963 |
|
|
2019
Q3 | $5.31M | Buy |
2,654,439
+1,333,333
| +101% | +$2.67M | 0.01% | 486 |
|
|
2019
Q2 | $2.85M | Sell |
1,321,106
-79,427
| -6% | -$172K | 0.01% | 667 |
|
|
2019
Q1 | $4.43M | Sell |
1,400,533
-1,691,600
| -55% | -$5.35M | 0.01% | 541 |
|
|
2018
Q4 | $7.7M | Hold |
3,092,133
| – | – | 0.02% | 372 |
|
|
2018
Q3 | $12.4M | Hold |
3,092,133
| – | – | 0.03% | 345 |
|
|
2018
Q2 | $11.7M | Hold |
3,092,133
| – | – | 0.03% | 345 |
|
|
2018
Q1 | $7.17M | Hold |
3,092,133
| – | – | 0.02% | 436 |
|
|
2017
Q4 | $4.79M | Hold |
3,092,133
| – | – | 0.01% | 529 |
|
|
2017
Q3 | $6.62M | Sell |
3,092,133
-1,306,742
| -30% | -$2.8M | 0.02% | 457 |
|
|
2017
Q2 | $19.9M | Buy |
4,398,875
+960,391
| +28% | +$4.34M | 0.05% | 260 |
|
|
2017
Q1 | $10.3M | Sell |
3,438,484
-70,504
| -2% | -$212K | 0.02% | 384 |
|
|
2016
Q4 | $9.69M | Sell |
3,508,988
-164,634
| -4% | -$454K | 0.02% | 384 |
|
|
2016
Q3 | $11.5M | Buy |
3,673,622
+797,523
| +28% | +$2.5M | 0.03% | 357 |
|
|
2016
Q2 | $14.8M | Sell |
2,876,099
-66,028
| -2% | -$339K | 0.04% | 343 |
|
|
2016
Q1 | $12M | Sell |
2,942,127
-7,215
| -0.2% | -$29.5K | 0.03% | 400 |
|
|
2015
Q4 | $23.9M | Buy |
2,949,342
+148,606
| +5% | +$1.21M | 0.05% | 282 |
|
|
2015
Q3 | $23.6M | Buy |
2,800,736
+964,836
| +53% | +$8.14M | 0.05% | 279 |
|
|
2015
Q2 | $17.3M | Buy |
1,835,900
+435,066
| +31% | +$4.09M | 0.03% | 358 |
|
|
2015
Q1 | $13M | Buy |
1,400,834
+190,191
| +16% | +$1.76M | 0.03% | 429 |
|
|
2014
Q4 | $11.2M | Buy |
1,210,643
+287,362
| +31% | +$2.66M | 0.02% | 472 |
|
|
2014
Q3 | $8.25M | Buy |
+923,281
| New | +$8.25M | 0.02% | 550 |
|